Prot# CRAD001C2410: A Phase II Trial of RAD001 in Patients with Recurrent Glioblastoma Multiforme

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/1/07 → 12/31/09

Funding

  • Novartis Pharmaceuticals Corporation (CRAD001C2410)